West Pharmaceutical Services announced an 18% increase in its fourth-quarter dividend to $0.26 per share, up from $0.22 last quarter. This marks the company's 34th consecutive annual dividend increase, reflecting its strong financial health and commitment to returning value to shareholders. The dividend will be paid on November 18, 2026, to shareholders recorded by November 11, 2026. West Pharmaceutical is a leading provider of injectable drug solutions, with significant global operations and $3.07 billion in net sales for fiscal year 2025.
West Pharmaceutical Services' quarterly dividend announcement is presented here with Pluang's Health sector market data as of Oct 20, 2026 04:11 WIB. Among 150 priced Health-sector US stocks tradable on Pluang, 84 rose and 65 fell today. Notable movers include Moderna, Inc. (MRNA) at USD 227.63 with a 1-day change of +4.41% and Pluang order activity of 34% Sell / 66% Buy, Iovance Biotherapeutics Inc. (IOVA) at USD 14.20 with a +4.26% change, and Cassava Sciences Inc. (FLNA) at USD 0.76 with a +4.00% change and 100% Buy order activity. The most notable figure is Moderna's price at USD 227.63.
XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...
XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...
Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
